Literature DB >> 19708095

An interim analysis of recruitment to the COLOFOL trial.

P Wille-Jørgensen1, S Laurberg, L Påhlman, L Carriquiry, N Lundqvist, K Smedh, M Svanfeldt, J Bengtson.   

Abstract

OBJECTIVE: To analyse the ongoing process of recruiting patients into a multicenter randomized trial on follow-up after curative surgery for colorectal cancer. The trial is registered in Clinical Trials Registration.
METHOD: Prospective registration of all operated patients as well as inclusions (curative resection, stage II or III disease, <or= 75 years, clean colon and exclusions of the individual patients in eight participating departments.
RESULTS: Between January 2006 and September 2007, 1309 patients have been operated upon. Of these 502 (38.3 %) met the inclusion criteria, 148 (29.5%) had exclusion criteria. Of the final eligible patients 241 (68.1%) were randomized. No specific barriers to inclusion were identified.
CONCLUSION: Of an overall population of patients operated for colorectal cancer about one in five were randomized. Bearing the rigorous inclusion and exclusion criteria in mind, this is considered satisfactory, and the investigated population may be representative of patients meeting the inclusion criteria.

Entities:  

Mesh:

Year:  2009        PMID: 19708095     DOI: 10.1111/j.1463-1318.2008.01668.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  14 in total

Review 1.  Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review.

Authors:  Knut Magne Augestad; Johnie Rose; Benjamin Crawshaw; Gregory Cooper; Conor Delaney
Journal:  World J Gastrointest Oncol       Date:  2014-05-15

Review 2.  Follow-up strategies for patients treated for non-metastatic colorectal cancer.

Authors:  Mark Jeffery; Brigid E Hickey; Phil N Hider; Adrienne M See
Journal:  Cochrane Database Syst Rev       Date:  2016-11-24

3.  Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.

Authors:  Rebecca A Snyder; Chung-Yuan Hu; Amanda Cuddy; Amanda B Francescatti; Jessica R Schumacher; Katherine Van Loon; Y Nancy You; Benjamin D Kozower; Caprice C Greenberg; Deborah Schrag; Alan Venook; Daniel McKellar; David P Winchester; George J Chang
Journal:  JAMA       Date:  2018-05-22       Impact factor: 56.272

4.  Surveillance for asymptomatic recurrence in resected stage III colon cancer: does it result in a more favorable outcome?

Authors:  Martin Smoragiewicz; Howard Lim; Renata D'Alpino Peixoto
Journal:  J Gastrointest Oncol       Date:  2015-06

Review 5.  Towards a personalised approach to aftercare: a review of cancer follow-up in the UK.

Authors:  Nicola J Davies; Lynn Batehup
Journal:  J Cancer Surviv       Date:  2011-01-21       Impact factor: 4.442

Review 6.  Surveillance after curative treatment for colorectal cancer.

Authors:  Eric P van der Stok; Manon C W Spaander; Dirk J Grünhagen; Cornelis Verhoef; Ernst J Kuipers
Journal:  Nat Rev Clin Oncol       Date:  2016-12-20       Impact factor: 66.675

Review 7.  Colorectal cancer surveillance: what's new and what's next.

Authors:  Johnie Rose; Knut Magne Augestad; Gregory S Cooper
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

8.  Follow-up strategies for patients treated for non-metastatic colorectal cancer.

Authors:  Mark Jeffery; Brigid E Hickey; Phillip N Hider
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04

9.  Validation of the Danish version of the disease specific instrument EORTC QLQ-CR38 to assess health-related quality of life in patients with colorectal cancer.

Authors:  Henriette Vind Thaysen; P Jess; Søren Laurberg; M Groenvold
Journal:  Health Qual Life Outcomes       Date:  2012-12-14       Impact factor: 3.186

10.  Cost-effectiveness and quality of life in surgeon versus general practitioner-organised colon cancer surveillance: a randomised controlled trial.

Authors:  Knut Magne Augestad; Jan Norum; Stefan Dehof; Ranveig Aspevik; Unni Ringberg; Torunn Nestvold; Barthold Vonen; Stein Olav Skrøvseth; Rolv-Ole Lindsetmo
Journal:  BMJ Open       Date:  2013-04-04       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.